JP2022542448A5 - - Google Patents
Info
- Publication number
- JP2022542448A5 JP2022542448A5 JP2022506468A JP2022506468A JP2022542448A5 JP 2022542448 A5 JP2022542448 A5 JP 2022542448A5 JP 2022506468 A JP2022506468 A JP 2022506468A JP 2022506468 A JP2022506468 A JP 2022506468A JP 2022542448 A5 JP2022542448 A5 JP 2022542448A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- residue corresponding
- acid residue
- sequence
- hla class
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962880509P | 2019-07-30 | 2019-07-30 | |
| US62/880,509 | 2019-07-30 | ||
| US202063029115P | 2020-05-22 | 2020-05-22 | |
| US63/029,115 | 2020-05-22 | ||
| PCT/IB2020/057174 WO2021019474A1 (en) | 2019-07-30 | 2020-07-29 | Mhc class ii molecules and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022542448A JP2022542448A (ja) | 2022-10-03 |
| JP2022542448A5 true JP2022542448A5 (https=) | 2023-08-08 |
| JP7811541B2 JP7811541B2 (ja) | 2026-02-05 |
Family
ID=74230294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506468A Active JP7811541B2 (ja) | 2019-07-30 | 2020-07-29 | Ｍｈｃクラスｉｉ分子及びその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220281949A1 (https=) |
| EP (1) | EP4004033A4 (https=) |
| JP (1) | JP7811541B2 (https=) |
| KR (1) | KR20220052944A (https=) |
| CN (1) | CN114502580B (https=) |
| AU (1) | AU2020319732A1 (https=) |
| BR (1) | BR112022001702A2 (https=) |
| CA (1) | CA3146296A1 (https=) |
| IL (1) | IL290231A (https=) |
| MX (1) | MX2022001211A (https=) |
| TW (1) | TW202118781A (https=) |
| WO (1) | WO2021019474A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3935175A4 (en) | 2019-03-04 | 2023-01-04 | University Health Network | T-LYMPHOCYTE RECEPTORS AND METHODS OF USE THEREOF |
| CN114450302A (zh) | 2019-07-30 | 2022-05-06 | 大学健康网络 | Mhc ii类分子及其使用方法 |
| BR112022001704A2 (pt) * | 2019-07-30 | 2022-07-05 | Univ Health Network | Moléculas mhc de classe ii e métodos de uso das mesmas |
| CN118662607A (zh) * | 2023-03-15 | 2024-09-20 | 中国科学院上海巴斯德研究所 | 抑制过激炎性反应的蛋白及其应用 |
| US20250074966A1 (en) * | 2023-08-31 | 2025-03-06 | Adaptive Biotechnologies Corporation | Agents and methods for preventing or inhibiting adaptive immune responses associated with multiple sclerosis |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4516916B2 (ja) * | 2003-07-11 | 2010-08-04 | 昇志 佐藤 | リビン由来のｈｌａ−ａ２４結合性癌抗原ペプチド |
| US20060228758A1 (en) | 2004-09-13 | 2006-10-12 | Xencor, Inc. | Analysis of MHC-peptide binding interactions |
| GB0911566D0 (en) * | 2009-07-03 | 2009-08-12 | Immunocore Ltd | T cell receptors |
| EP2859017B1 (en) * | 2012-06-08 | 2019-02-20 | Sutro Biopharma, Inc. | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use |
| US9717758B2 (en) * | 2013-05-17 | 2017-08-01 | University Of Massachusetts | High-affinity DMF5 T cell receptor (TCR) variants |
| WO2016135363A1 (es) | 2015-02-23 | 2016-09-01 | Servicio Andaluz De Salud | Método de obtención de datos útiles para predecir o pronosticar la transmisión vertical, la cronificación y/o el aclaramiento del virus de la hepatitis c |
| EP4212547A1 (en) * | 2015-12-03 | 2023-07-19 | Juno Therapeutics, Inc. | Modified chimeric receptors and related compositions and methods |
| WO2017106684A2 (en) * | 2015-12-17 | 2017-06-22 | Janssen Biotech, Inc. | Antibodies specifically binding hla-dr and their uses |
| GB201604492D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Transfected t-cells and t-cell receptors for use in immunotherapy against cancers |
| US12187781B2 (en) * | 2018-08-01 | 2025-01-07 | Regents Of The University Of Minnesota | Co-receptor affinity enhanced major histocompatibility class II molecules |
-
2020
- 2020-07-29 CN CN202080068318.7A patent/CN114502580B/zh active Active
- 2020-07-29 AU AU2020319732A patent/AU2020319732A1/en active Pending
- 2020-07-29 KR KR1020227006945A patent/KR20220052944A/ko active Pending
- 2020-07-29 MX MX2022001211A patent/MX2022001211A/es unknown
- 2020-07-29 JP JP2022506468A patent/JP7811541B2/ja active Active
- 2020-07-29 US US17/631,824 patent/US20220281949A1/en active Pending
- 2020-07-29 CA CA3146296A patent/CA3146296A1/en active Pending
- 2020-07-29 WO PCT/IB2020/057174 patent/WO2021019474A1/en not_active Ceased
- 2020-07-29 TW TW109125667A patent/TW202118781A/zh unknown
- 2020-07-29 BR BR112022001702A patent/BR112022001702A2/pt unknown
- 2020-07-29 EP EP20847581.4A patent/EP4004033A4/en active Pending
-
2022
- 2022-01-30 IL IL290231A patent/IL290231A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022542448A5 (https=) | ||
| TWI835730B (zh) | Ｔｃｒ及肽 | |
| Hamada et al. | Association of immunoglobulin G Fc receptor II with Src-like protein-tyrosine kinase Fgr in neutrophils. | |
| Bachem et al. | Superior antigen cross-presentation and XCR1 expression define human CD11c+ CD141+ cells as homologues of mouse CD8+ dendritic cells | |
| CN114502580B (zh) | Mhc ii类分子及其使用方法 | |
| WO2016184592A1 (en) | T cell receptor with specificity for myeloperoxidase peptide and uses thereof | |
| Zhang et al. | The effect of adjuvanting cancer vaccines with herpes simplex virus glycoprotein D on melanoma-driven CD8+ T cell exhaustion | |
| US20190389926A1 (en) | Mr1 restricted t cell receptors for cancer immunotherapy | |
| CN111032686A (zh) | 血液恶性肿瘤的治疗 | |
| JP2022542447A5 (https=) | ||
| US20220339271A1 (en) | Mr1 restricted t cell receptors for cancer immunotherapy | |
| CA3115022A1 (en) | Specific t cell receptors against epitopes of mutant myd88l265p protein for adoptive t cell therapy | |
| JP2022542445A5 (https=) | ||
| JP7811540B2 (ja) | Ｍｈｃクラスｉｉ分子及びその使用方法 | |
| Kim et al. | In vitro induction of HLA-A2402-restricted and carcinoembryonic-antigen-specific cytotoxic T lymphocytes on fixed autologous peripheral blood cells | |
| JP2022527322A5 (https=) | ||
| TWI881991B (zh) | Ｉｉ類ｍｈｃ分子及其使用方法 | |
| EP4735471A2 (en) | T-cell receptors | |
| EP4731758A2 (en) | Antigen-specific t cell receptors and chimeric antigen receptors, and methods of use in immune signaling modulation for cancer immunotherapy | |
| EP4491630A1 (en) | T-cell receptor for acute myeloid leukemia (aml) | |
| WO2021060343A1 (ja) | Ｕｒｌｃ１０由来ペプチドまたはｄｅｐｄｃ１由来ペプチドを認識するヒトｔ細胞が発現するｔ細胞受容体 | |
| CN119256084A (zh) | 血液系统恶性肿瘤的治疗 | |
| Aptsiauri et al. | MHC Class I antigens and the tumor microenvironment | |
| Carr | Mechanisms of NK cell recognition of HCMV infected cells | |
| JP2022191531A (ja) | Ｕｒｌｃ１０由来ペプチドまたはｄｅｐｄｃ１由来ペプチドを認識するヒトｔ細胞が発現するｔ細胞受容体 |